Samuel A Hamood's Net Worth
$2.16 Million
Who is Samuel A Hamood?
Samuel A Hamood has an estimated net worth of $2.16 Million. This is based on reported shares across multiple companies, which include TransUnion, Definitive Healthcare Corp., and Finch Therapeutics Group, Inc..
SEC CIK
Samuel A Hamood's CIK is 0001645772
Past Insider Trading and Trends
2022 was Samuel A Hamood's most active year for acquiring shares with 2 total transactions. Samuel A Hamood's most active month to acquire stocks was the month of January. 2022 saw Samuel A Hamood paying a total of $0.00 for 59,388 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TransUnion (TRU) Snapshot price: $94.18
EVP & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +31.47% | 18.84K |
$23.97 | -$716,072.80 | 78.72K |
Sep 14
| |||
Form 4
| -70.77% | -145.00K |
$39.15 | -$5,676,750.00 | 59.88K |
May 2
| |||
Form 4
| +414.40% | 165.05K |
$21.29 | -$5,229,950.43 | 204.88K |
Mar 15
| |||
Form 4
| -60.10% | -60.00K |
$20.81 | -$2,540,493.51 | 39.83K |
Scheduled
|
Feb 21 - Feb 22
| ||
Form 4
|
∞
| 20.24K |
—
|
—
| 20.24K |
Feb 17
| |||
Form 4
| -20.20% | -25.23K |
$29.66 | -$748,333.12 | 99.64K |
Scheduled
|
Nov 14
| ||
Form 4
| -19.37% | -30.00K |
$32.82 | -$984,600.00 | 124.87K |
Sep 14
| |||
Form 4
| -14.01% | -25.23K |
$32.35 | -$816,125.80 | 154.87K |
Scheduled
|
Aug 15
| ||
Form 4
| -15.19% | -25.23K |
$31.36 | -$791,150.08 | 140.89K |
Scheduled
|
May 16
| ||
Form 4
| +28.17% | 38.54K |
—
|
—
| 175.35K |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Definitive Healthcare Corp. (DH) Snapshot price: $4.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +83.41% | 26.76K |
—
|
—
| 58.84K |
May 22
| |||
Form 4
| +120.56% | 17.54K |
—
|
—
| 32.08K |
Jun 1
| |||
Form 4
| +39.27% | 14.54K |
—
|
—
| 51.58K |
May 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Finch Therapeutics Group, Inc. (FNCH) Snapshot price: $12.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||